🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,94 USD

Máx. histórico

156,45

72 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,08%

Rango 52 semanas

84,35 – 156,92

Variación hoy

-2,28%

Cierre anterior

150,36

Rango de hoy

146,55 – 153,37

Volumen hoy

11.428.734

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,42 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 10 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,31%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/03/2020 73,60 77,81 73,55 77,64 +6,28% 5,80% 18.840.525
28/02/2020 73,17 73,94 70,78 73,05 -1,95% 4,32% 29.246.117
27/02/2020 77,01 78,01 74,43 74,50 -2,33% 4,65% 15.734.253
26/02/2020 76,97 77,89 76,12 76,28 -0,41% 2,31% 11.940.283
25/02/2020 77,80 78,19 76,19 76,59 -1,30% 2,56% 13.171.683
24/02/2020 76,92 78,81 76,88 77,61 -1,23% 2,51% 13.734.145
21/02/2020 78,43 78,85 77,97 78,57 -0,18% 1,12% 9.295.970
20/02/2020 78,45 79,04 77,98 78,71 +0,60% 1,35% 10.941.330
19/02/2020 79,27 79,30 77,83 78,24 -0,56% 1,85% 11.740.220
18/02/2020 79,08 79,30 78,49 78,68 -0,23% 1,03% 10.017.308
14/02/2020 78,46 79,01 77,93 78,86 +0,83% 1,37% 8.743.464
13/02/2020 79,13 79,13 77,72 78,22 -1,54% 1,78% 19.388.734
12/02/2020 81,15 81,33 79,10 79,44 -2,35% 2,74% 19.630.926
11/02/2020 81,93 82,06 81,06 81,35 -0,48% 1,22% 10.252.689
10/02/2020 81,18 82,04 81,05 81,74 +0,68% 1,22% 10.590.983
07/02/2020 81,96 82,00 80,94 81,18 -0,70% 1,29% 11.419.427
06/02/2020 82,08 82,28 81,36 81,76 -0,17% 1,13% 16.110.170
05/02/2020 80,80 82,77 80,15 81,90 -2,86% 3,24% 29.290.133
04/02/2020 84,38 85,11 84,03 84,31 +1,17% 1,29% 15.091.305
03/02/2020 82,10 84,18 82,10 83,34 +2,22% 2,53% 9.729.318
31/01/2020 82,42 82,70 81,11 81,53 -1,23% 1,93% 9.621.583
30/01/2020 82,97 83,14 82,25 82,54 -0,85% 1,07% 11.016.471
29/01/2020 82,63 84,12 82,47 83,24 +1,15% 2,00% 8.511.227
28/01/2020 82,48 82,74 81,97 82,30 +0,17% 0,94% 9.496.347
27/01/2020 81,20 82,55 80,83 82,16 +0,14% 2,12% 10.847.534
24/01/2020 84,57 84,76 81,66 82,04 -2,91% 3,67% 14.954.960
23/01/2020 85,55 85,55 84,22 84,50 -1,22% 1,56% 13.198.093
22/01/2020 86,04 86,32 85,52 85,54 -0,36% 0,93% 7.800.474
21/01/2020 86,56 86,80 85,60 85,85 -1,10% 1,39% 10.022.129
17/01/2020 87,10 87,43 86,70 86,80 -0,23% 0,84% 10.131.226